Immunotherapy/Antibody Therapeutics companies

We are a life science venture capital investor, delivering knowledge, network, and capital to companies.

The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.

Accelerating life-extending therapies, treatments and cures for all myeloma patients.

Curie.Bio is a new model for venture capital in biotech. We are focused on a singular mission – helping founders launch therapeutics companies that go on to rai…